APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microbiology Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Microbiology Software Market Outlook and Growth Opportunities 2026

28 December 2025194 pages

Choose your research edition.

Industry ResearchMicrobiology Software Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Microbiology Software Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Microbiology Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microbiology Software Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Microbiology Software Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Microbiology Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Microbiology Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Microbiology Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microbiology Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Microbiology Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Microbiology Software market include ERBA Diagnostics Mannheim, GSL Biotech, Micronbrane Medical, Synbiosis, Charles River Laboratories, SCC SOFT COMPUTER, Systec GmbH & Co. KG., i2a (intelligence artificielle applications) S.A. and Soft Computer Consultants, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Microbiology Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Microbiology Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Microbiology Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Microbiology Software market.

Microbiology Software Segment by Company

ERBA Diagnostics Mannheim

GSL Biotech

Micronbrane Medical

Synbiosis

Charles River Laboratories

SCC SOFT COMPUTER

Systec GmbH & Co. KG.

i2a (intelligence artificielle applications) S.A.

Soft Computer Consultants

Clover Bioanalytical Software

Microbiology Software Segment by Type

Cloud Based

On-Premises

Microbiology Software Segment by Application

Pharmaceutical and Biotechnology Industry

Academic and Research Centers

Hospital

Others

Microbiology Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Microbiology Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Microbiology Software key companies, revenue, market share, and recent developments.

3. To split the Microbiology Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Microbiology Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Microbiology Software significant trends, drivers, influence factors in global and regions.

6. To analyze Microbiology Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbiology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microbiology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbiology Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Microbiology Software industry.

Chapter 3: Detailed analysis of Microbiology Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Microbiology Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Microbiology Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Microbiology Software Industry Trends Table 2. Microbiology Software Industry Drivers Table 3. Microbiology Software Industry Opportunities and Challenges Table 4. Microbiology Software Industry Restraints Table 5. Global Microbiology Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Microbiology Software Revenue Share by Company (2021-2026) Table 7. Global Microbiology Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Microbiology Software Key Company Manufacturing Base & Headquarters Table 9. Global Microbiology Software Company, Product Type & Application Table 10. Global Microbiology Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Microbiology Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud Based Table 15. Significant Companies of On-Premises Table 16. Global Microbiology Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Microbiology Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Microbiology Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Microbiology Software Sales Value Share by Type (2021-2026) Table 20. Global Microbiology Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceutical and Biotechnology Industry Table 22. Significant Companies of Academic and Research Centers Table 23. Significant Companies of Hospital Table 24. Significant Companies of Others Table 25. Global Microbiology Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Microbiology Software Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Microbiology Software Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Microbiology Software Sales Value Share by Application (2021-2026) Table 29. Global Microbiology Software Sales Value Share by Application (2027-2032) Table 30. Global Microbiology Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Microbiology Software Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Microbiology Software Sales Value Share by Region (2021-2026) Table 33. Global Microbiology Software Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Microbiology Software Sales Value Share by Region (2027-2032) Table 35. Global Microbiology Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Microbiology Software Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Microbiology Software Sales Value Market Share by Country (2021-2026) Table 38. Global Microbiology Software Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Microbiology Software Sales Value Market Share by Country (2027-2032) Table 40. ERBA Diagnostics Mannheim Company Information Table 41. ERBA Diagnostics Mannheim Business Overview Table 42. ERBA Diagnostics Mannheim Microbiology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. ERBA Diagnostics Mannheim Microbiology Software Product Portfolio Table 44. ERBA Diagnostics Mannheim Recent Development Table 45. GSL Biotech Company Information Table 46. GSL Biotech Business Overview Table 47. GSL Biotech Microbiology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. GSL Biotech Microbiology Software Product Portfolio Table 49. GSL Biotech Recent Development Table 50. Micronbrane Medical Company Information Table 51. Micronbrane Medical Business Overview Table 52. Micronbrane Medical Microbiology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Micronbrane Medical Microbiology Software Product Portfolio Table 54. Micronbrane Medical Recent Development Table 55. Synbiosis Company Information Table 56. Synbiosis Business Overview Table 57. Synbiosis Microbiology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Synbiosis Microbiology Software Product Portfolio Table 59. Synbiosis Recent Development Table 60. Charles River Laboratories Company Information Table 61. Charles River Laboratories Business Overview Table 62. Charles River Laboratories Microbiology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Charles River Laboratories Microbiology Software Product Portfolio Table 64. Charles River Laboratories Recent Development Table 65. SCC SOFT COMPUTER Company Information Table 66. SCC SOFT COMPUTER Business Overview Table 67. SCC SOFT COMPUTER Microbiology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. SCC SOFT COMPUTER Microbiology Software Product Portfolio Table 69. SCC SOFT COMPUTER Recent Development Table 70. Systec GmbH & Co. KG. Company Information Table 71. Systec GmbH & Co. KG. Business Overview Table 72. Systec GmbH & Co. KG. Microbiology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Systec GmbH & Co. KG. Microbiology Software Product Portfolio Table 74. Systec GmbH & Co. KG. Recent Development Table 75. i2a (intelligence artificielle applications) S.A. Company Information Table 76. i2a (intelligence artificielle applications) S.A. Business Overview Table 77. i2a (intelligence artificielle applications) S.A. Microbiology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. i2a (intelligence artificielle applications) S.A. Microbiology Software Product Portfolio Table 79. i2a (intelligence artificielle applications) S.A. Recent Development Table 80. Soft Computer Consultants Company Information Table 81. Soft Computer Consultants Business Overview Table 82. Soft Computer Consultants Microbiology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Soft Computer Consultants Microbiology Software Product Portfolio Table 84. Soft Computer Consultants Recent Development Table 85. Clover Bioanalytical Software Company Information Table 86. Clover Bioanalytical Software Business Overview Table 87. Clover Bioanalytical Software Microbiology Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Clover Bioanalytical Software Microbiology Software Product Portfolio Table 89. Clover Bioanalytical Software Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Microbiology Software Product Image Figure 2. Global Microbiology Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microbiology Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Microbiology Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud Based Image Figure 8. On-Premises Image Figure 9. Global Microbiology Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Microbiology Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Microbiology Software Sales Value Share by Type (2021-2032) Figure 12. Pharmaceutical and Biotechnology Industry Image Figure 13. Academic and Research Centers Image Figure 14. Hospital Image Figure 15. Others Image Figure 16. Global Microbiology Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Microbiology Software Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Microbiology Software Sales Value Share by Application (2021-2032) Figure 19. Global Microbiology Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Microbiology Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Microbiology Software Sales Value (2021-2032) & (US$ Million) Figure 22. North America Microbiology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Microbiology Software Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Microbiology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Microbiology Software Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Microbiology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Microbiology Software Sales Value (2021-2032) & (US$ Million) Figure 28. South America Microbiology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Microbiology Software Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Microbiology Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Microbiology Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Microbiology Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Microbiology Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud Based
  • On-Premises
Applications
  • Pharmaceutical and Biotechnology Industry
  • Academic and Research Centers
  • Hospital
  • Others
Companies covered
  • ERBA Diagnostics Mannheim
  • GSL Biotech
  • Micronbrane Medical
  • Synbiosis
  • Charles River Laboratories
  • SCC SOFT COMPUTER
  • Systec GmbH & Co. KG.
  • i2a (intelligence artificielle applications) S.A.
  • Soft Computer Consultants
  • Clover Bioanalytical Software

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Microbiology Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Microbiology Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Microbiology Software Market Dynamics
  1. 2.1 Microbiology Software Industry Trends
  2. 2.2 Microbiology Software Industry Drivers
  3. 2.3 Microbiology Software Industry Opportunities and Challenges
  4. 2.4 Microbiology Software Industry Restraints
3 Microbiology Software Market by Company
  1. 3.1 Global Microbiology Software Company Revenue Ranking in 2025
  2. 3.2 Global Microbiology Software Revenue by Company (2021-2026)
  3. 3.3 Global Microbiology Software Company Ranking (2024-2026)
  4. 3.4 Global Microbiology Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Microbiology Software Company Product Type and Application
  6. 3.6 Global Microbiology Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Microbiology Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Microbiology Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Microbiology Software Market by Type
  1. 4.1 Microbiology Software Type Introduction
  2. 4.1.1 Cloud Based
  3. 4.1.2 On-Premises
  4. 4.2 Global Microbiology Software Sales Value by Type
  5. 4.2.1 Global Microbiology Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Microbiology Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Microbiology Software Sales Value Share by Type (2021-2032)
5 Microbiology Software Market by Application
  1. 5.1 Microbiology Software Application Introduction
  2. 5.1.1 Pharmaceutical and Biotechnology Industry
  3. 5.1.2 Academic and Research Centers
  4. 5.1.3 Hospital
  5. 5.1.4 Others
  6. 5.2 Global Microbiology Software Sales Value by Application
  7. 5.2.1 Global Microbiology Software Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Microbiology Software Sales Value by Application (2021-2032)
  9. 5.2.3 Global Microbiology Software Sales Value Share by Application (2021-2032)
6 Microbiology Software Regional Value Analysis
  1. 6.1 Global Microbiology Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Microbiology Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Microbiology Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Microbiology Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Microbiology Software Sales Value (2021-2032)
  7. 6.3.2 North America Microbiology Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Microbiology Software Sales Value (2021-2032)
  10. 6.4.2 Europe Microbiology Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Microbiology Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Microbiology Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Microbiology Software Sales Value (2021-2032)
  16. 6.6.2 South America Microbiology Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Microbiology Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Microbiology Software Sales Value Share by Country, 2025 VS 2032
7 Microbiology Software Country-level Value Analysis
  1. 7.1 Global Microbiology Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Microbiology Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Microbiology Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Microbiology Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Microbiology Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Microbiology Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Microbiology Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Microbiology Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Microbiology Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Microbiology Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Microbiology Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Microbiology Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Microbiology Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Microbiology Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Microbiology Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Microbiology Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Microbiology Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Microbiology Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Microbiology Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Microbiology Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Microbiology Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Microbiology Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Microbiology Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Microbiology Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Microbiology Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Microbiology Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Microbiology Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Microbiology Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Microbiology Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Microbiology Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Microbiology Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Microbiology Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Microbiology Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Microbiology Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Microbiology Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Microbiology Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Microbiology Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Microbiology Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Microbiology Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Microbiology Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Microbiology Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Microbiology Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Microbiology Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Microbiology Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Microbiology Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Microbiology Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Microbiology Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Microbiology Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Microbiology Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Microbiology Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Microbiology Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Microbiology Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Microbiology Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Microbiology Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Microbiology Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Microbiology Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Microbiology Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Microbiology Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Microbiology Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Microbiology Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Microbiology Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Microbiology Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Microbiology Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Microbiology Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Microbiology Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Microbiology Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Microbiology Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Microbiology Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Microbiology Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Microbiology Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Microbiology Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Microbiology Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Microbiology Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Microbiology Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Microbiology Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Microbiology Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Microbiology Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Microbiology Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Microbiology Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Microbiology Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Microbiology Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Microbiology Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Microbiology Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Microbiology Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Microbiology Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Microbiology Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Microbiology Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Microbiology Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ERBA Diagnostics Mannheim
  2. 8.1.1 ERBA Diagnostics Mannheim Company Information
  3. 8.1.2 ERBA Diagnostics Mannheim Business Overview
  4. 8.1.3 ERBA Diagnostics Mannheim Microbiology Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ERBA Diagnostics Mannheim Microbiology Software Product Portfolio
  6. 8.1.5 ERBA Diagnostics Mannheim Recent Developments
  7. 8.2 GSL Biotech
  8. 8.2.1 GSL Biotech Company Information
  9. 8.2.2 GSL Biotech Business Overview
  10. 8.2.3 GSL Biotech Microbiology Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GSL Biotech Microbiology Software Product Portfolio
  12. 8.2.5 GSL Biotech Recent Developments
  13. 8.3 Micronbrane Medical
  14. 8.3.1 Micronbrane Medical Company Information
  15. 8.3.2 Micronbrane Medical Business Overview
  16. 8.3.3 Micronbrane Medical Microbiology Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Micronbrane Medical Microbiology Software Product Portfolio
  18. 8.3.5 Micronbrane Medical Recent Developments
  19. 8.4 Synbiosis
  20. 8.4.1 Synbiosis Company Information
  21. 8.4.2 Synbiosis Business Overview
  22. 8.4.3 Synbiosis Microbiology Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Synbiosis Microbiology Software Product Portfolio
  24. 8.4.5 Synbiosis Recent Developments
  25. 8.5 Charles River Laboratories
  26. 8.5.1 Charles River Laboratories Company Information
  27. 8.5.2 Charles River Laboratories Business Overview
  28. 8.5.3 Charles River Laboratories Microbiology Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Charles River Laboratories Microbiology Software Product Portfolio
  30. 8.5.5 Charles River Laboratories Recent Developments
  31. 8.6 SCC SOFT COMPUTER
  32. 8.6.1 SCC SOFT COMPUTER Company Information
  33. 8.6.2 SCC SOFT COMPUTER Business Overview
  34. 8.6.3 SCC SOFT COMPUTER Microbiology Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SCC SOFT COMPUTER Microbiology Software Product Portfolio
  36. 8.6.5 SCC SOFT COMPUTER Recent Developments
  37. 8.7 Systec GmbH & Co. KG.
  38. 8.7.1 Systec GmbH & Co. KG. Company Information
  39. 8.7.2 Systec GmbH & Co. KG. Business Overview
  40. 8.7.3 Systec GmbH & Co. KG. Microbiology Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Systec GmbH & Co. KG. Microbiology Software Product Portfolio
  42. 8.7.5 Systec GmbH & Co. KG. Recent Developments
  43. 8.8 i2a (intelligence artificielle applications) S.A.
  44. 8.8.1 i2a (intelligence artificielle applications) S.A. Company Information
  45. 8.8.2 i2a (intelligence artificielle applications) S.A. Business Overview
  46. 8.8.3 i2a (intelligence artificielle applications) S.A. Microbiology Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 i2a (intelligence artificielle applications) S.A. Microbiology Software Product Portfolio
  48. 8.8.5 i2a (intelligence artificielle applications) S.A. Recent Developments
  49. 8.9 Soft Computer Consultants
  50. 8.9.1 Soft Computer Consultants Company Information
  51. 8.9.2 Soft Computer Consultants Business Overview
  52. 8.9.3 Soft Computer Consultants Microbiology Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Soft Computer Consultants Microbiology Software Product Portfolio
  54. 8.9.5 Soft Computer Consultants Recent Developments
  55. 8.10 Clover Bioanalytical Software
  56. 8.10.1 Clover Bioanalytical Software Company Information
  57. 8.10.2 Clover Bioanalytical Software Business Overview
  58. 8.10.3 Clover Bioanalytical Software Microbiology Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Clover Bioanalytical Software Microbiology Software Product Portfolio
  60. 8.10.5 Clover Bioanalytical Software Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst